A breakthrough study highlights WNT9B variants as significant risk factors for prostate cancer. Learn more: hubs.la/Q036MWGJ0

Could Botox injections offer better symptom relief than traditional therapies for overweight women with refractory OAB? Find out here: hubs.la/Q037thgj0

New research highlights a potential way to make prostate biopsies more tolerable using classical music. Read more: hubs.la/Q038-rkf0

A study of 1.29 million individuals reveals new insights into bladder medication use and cognitive health. What could this mean for long-term treatment strategies? Learn more: hubs.la/Q039Tfj10

Could sex hormones influence kidney cancer risk? Find out on EMJ: hubs.la/Q03bXkym0

The evolution of #ProstateCancer treatment: Discover how laparoscopic radical prostatectomy is challenging traditional surgical approaches with promising results for patients. 🔗: hubs.la/Q03c1H0P0

From robotics in reconstructive urology to greener innovations, the EMJ team are on the ground ready to learn all the latest from the experts at European Association of Urology (EAU)'s #EAU25 Subscribe to EMJ Urology so you don't miss out on our upcoming congress review: hubs.la/Q03cTBpG0

A new AI-powered tool, the CHAI platform, is transforming risk prediction in bladder cancer. 🔗 Learn more: hubs.la/Q03dGJZD0

Precision medicine is shaping prostate cancer treatment. A new trial in China is evaluating biomarker-guided neoadjuvant therapy to improve outcomes. Read more: hubs.la/Q03fX9VH0

Could proteinuria be an early warning sign of sudden cardiac arrest in young adults? New research suggests a 71% higher risk, even in those without pre-existing conditions. Find out more: hubs.la/Q03gwyCZ0

A new UK study shows that a simple spit test using polygenic risk scores (PRS) outperforms the PSA blood test for prostate cancer screening — detecting more high-risk cases and reducing false positives. Learn more: hubs.la/Q03gMVdd0 #Urology #ProstateCancer

A new study suggests an alternative treatment offers the same survival benefit as conventional radiotherapy for localised prostate cancer—without added toxicity. Explore the full study: hubs.la/Q03h925p0

A major UK trial finds urodynamics add no value for women with refractory overactive bladder. Clinical assessment alone led to faster treatment and better short-term outcomes, without any extra cost. Full story here: hubs.la/Q03jWtvk0

"AI and precision medicine are reshaping the future of urology—this is just the beginning." Maarten Albersen, UZ Leuven highlights the evolving role of AI and precision medicine in urology, discussing how these technologies are transforming diagnostics: hubs.la/Q03k1Bc80

The Stockholm3 blood test shows comparable sensitivity to PSA but with significantly higher specificity and fewer unnecessary biopsies. Learn more: hubs.la/Q03kq4P50 #ProstateCancerScreening #Biomarkers #ClinicalTrials

Uncover the latest insights in Urology in our new journal: hubs.la/Q03kBw3h0 Inside, discover learnings from EAU 2025, expert interviews and much more. Don't miss out on the future of urological care 🔗hubs.la/Q03kBw3h0

Older adults undergoing urologic procedures have a significantly higher risk of invasive E. coli disease compared to those not. Learn why: hubs.la/Q03nh0dZ0

A study has identified a new prostate cancer risk gene. Discover more: hubs.la/Q03qQmqD0

Nighttime urine collection is not a reliable replacement for 24-hour sampling to estimate daily sodium intake, a new study shows. Read here: hubs.la/Q03r-qhg0